Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck

Published:2018-05-09 Issue:14 Volume:124 Page:2986-2992
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Weiss Jared M.¹^ORCID,Grilley-Olson Juneko E.¹,Deal Allison Mary²,Zevallos Jose P.³,Chera Bhishamjit S.⁴^ORCID,Paul Jennifer¹,Knowles Mary Fleming⁴,Usenko Dmitriy¹,Weissler Mark C.⁵,Patel Samip⁵,Hayes David N.⁶,Hackman Trevor⁵

Affiliation:

1. Department of Hematology and Oncology; Lineberger Comprehensive Cancer Center at the University of North Carolina; Chapel Hill North Carolina

2. Lineberger Cancer Center at the University of North Carolina; Chapel Hill North Carolina

3. Head and Neck Surgical Oncology; Washington University School of Medicine; St Louis Missouri

4. Department of Radiation Oncology; Lineberger Comprehensive Cancer Center at the University of North Carolina; Chapel Hill North Carolina

5. Division of Head and Neck Surgery, Department of Otolaryngology; Lineberger Comprehensive Cancer Center at the University of North Carolina; Chapel Hill North Carolina

6. West Cancer Center; Germantown Tennessee

Funder

Novartis

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trials;Holsinger;J Clin Oncol,2015

2. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

3. DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN) [abstract];Cohen;J Clin Oncol.,2012

4. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial;Haddad;Lancet Oncol,2013

5. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of elderly patients with head and neck cancer in an aging society: Focus on geriatric assessment and surgical treatment;Auris Nasus Larynx;2024-08

2. Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV⁺ Oropharyngeal Cancer;JAMA Oncology;2024-07-01

3. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21

4. Neoadjuvant chemotherapy enhances tumor‐specific T cell immunity in patients with HPV‐associated oropharyngeal cancer;Head & Neck;2023-07-21

5. A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma;Cancer;2023-07-03